Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain.

Código QR

Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain.

Guardado en:

Detalles Bibliográficos
Autores principales:	Axel T Brunger, Mark A Breidenbach, Rongsheng Jin, Audrey Fischer, Jose S Santos, Mauricio Montal
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2007
Materias:	Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/71bee96a6acf498585c05a2872aac763
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

On Botulinum Neurotoxin Variability
por: Cesare Montecucco, et al.
Publicado: (2015)

The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes
por: Sabine Pellett, et al.
Publicado: (2018)

Identification and characterization of a novel botulinum neurotoxin
por: Sicai Zhang, et al.
Publicado: (2017)

Neurologic uses of botulinum neurotoxin type A
por: John P Ney, et al.
Publicado: (2007)

A viral-fusion-peptide-like molecular switch drives membrane insertion of botulinum neurotoxin A1
por: Kwok-ho Lam, et al.
Publicado: (2018)

Recombinant botulinum neurotoxin serotype A1 in vivo characterization
por: Cindy Périer, et al.
Publicado: (2021)

Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6
por: Molly S. Moritz, et al.
Publicado: (2018)

A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding
por: Guorui Yao, et al.
Publicado: (2017)

Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
por: Liang Tao, et al.
Publicado: (2017)

Blink index as a response predictor of blepharospasm to botulinum neurotoxin‐A treatment
por: Jeongkyeong Jang, et al.
Publicado: (2021)

Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E
por: Priyanka Sonkar, et al.
Publicado: (2020)

Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy
por: Siro Luvisetto
Publicado: (2021)

Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC
por: Sicai Zhang, et al.
Publicado: (2017)

Dynamic intramolecular regulation of the histone chaperone nucleoplasmin controls histone binding and release
por: Christopher Warren, et al.
Publicado: (2017)

Knockin mouse models demonstrate differential contributions of synaptotagmin-1 and -2 as receptors for botulinum neurotoxins.
por: Hatim Thaker, et al.
Publicado: (2021)

Botulinum Neurotoxin Type A in the Treatment of Facial Seborrhea and Acne: Evidence and a Proposed Mechanism
por: Nark-Kyoung Rho, et al.
Publicado: (2021)

Botulinum Neurotoxin-Producing Bacteria. Isn’t It Time that We Called a Species a Species?
por: Theresa Smith, et al.
Publicado: (2018)

Intratracheal inoculation of AHc vaccine induces protection against aerosolized botulinum neurotoxin A challenge in mice
por: Changjiao Gan, et al.
Publicado: (2021)

The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes.
por: Sara Marinelli, et al.
Publicado: (2012)

Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified <named-content content-type="genus-species">Clostridium botulinum</named-content> Strain
por: Sabine Pellett, et al.
Publicado: (2016)

The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach
por: Rafael Ríos-Tamayo, et al.
Publicado: (2021)

Polyclonal light chains in cerebrovascular disease
por: Patrizia Fiori, et al.
Publicado: (2010)

Affinity biosensors using recombinant native membrane proteins displayed on exosomes: application to botulinum neurotoxin B receptor
por: Richard Desplantes, et al.
Publicado: (2017)

Horse immunization with short-chain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous species
por: Guillermo de la Rosa, et al.
Publicado: (2019)

Intramolecular chaperone-mediated secretion of an Rhs effector toxin by a type VI secretion system
por: Tong-Tong Pei, et al.
Publicado: (2020)

Neuromuscular junction defects in mice with mutation of dynein heavy chain 1.
por: Stephanie L Courchesne, et al.
Publicado: (2011)

Tracing heavy metals in ‘swine manure - maggot - chicken’ production chain
por: Wanqiang Wang, et al.
Publicado: (2017)

Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins
por: Toshiaki Takeuchi, et al.
Publicado: (2021)

Neurotoxin Botulinum Inserts Apoptotic Effects on Certain Cancer Cell Lines Via Neural Niche of Tumors: A Molecular Study
por: Mona Farhadi, et al.
Publicado: (2020)

Use-dependent potentiation of voltage-gated calcium channels rescues neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A
por: Phillip H. Beske, et al.
Publicado: (2017)

Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin
por: Nai-Jia Huang, et al.
Publicado: (2017)

Deciphering the importance of the palindromic architecture of the immunoglobulin heavy-chain 3’ regulatory region
por: Alexis Saintamand, et al.
Publicado: (2016)

The possible role of Myosin light chain in myoblast proliferation
por: ZHANG,SU-ZHEN, et al.
Publicado: (2009)

Seven day pre-analytical stability of serum and plasma neurofilament light chain
por: Patrick Altmann, et al.
Publicado: (2021)

Publisher Correction: Intramolecular chaperone-mediated secretion of an Rhs effector toxin by a type VI secretion system
por: Tong-Tong Pei, et al.
Publicado: (2020)

Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A).
por: Birgitte P S Jacky, et al.
Publicado: (2013)

Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction.
por: Pål Stenmark, et al.
Publicado: (2008)

Intrathecal kappa free light chains as markers for multiple sclerosis
por: D. Vecchio, et al.
Publicado: (2020)

Dynamic regulation of myosin light chain phosphorylation by Rho-kinase.
por: Takako Kaneko-Kawano, et al.
Publicado: (2012)

Neurofilament Light Chain Is a Promising Biomarker in Alcohol Dependence
por: Yanfei Li, et al.
Publicado: (2021)